Orchestra BioMed Holdings, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Orchestra BioMed Holdings, Inc. reported Cash And Cash Equivalents At Carrying Value of $34.69 million for the year ending 2025.

  • Orchestra BioMed Holdings, Inc. showed an increase of +55.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Orchestra BioMed Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Orchestra BioMed Holdings, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,611.5%.
  • Historical annual values: Fiscal year 2025: $34.69 million | Fiscal year 2024: $22.26 million | Fiscal year 2023: $30.56 million | Fiscal year 2022: $19.78 million | Fiscal year 2021: $1.75 million | Fiscal year 2020: $2.03 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: